文献速递脑血管病外科小儿神经外科与脑积水

伽玛刀放射外科治疗儿童脑动静脉畸形的长期结局:第一部分——畸形血管巢闭塞率及相关因素分析

Long-Term Outcomes for Pediatric Patients with Brain Arteriovenous Malformations Treated with Gamma Knife Radiosurgery, Part 1: Analysis of Nidus Obliteration Rates and Related Factors.
PubMed 文献 · World Neurosurg · 2019-03-25

本研究纳入189例年龄≤15岁、接受伽玛刀放射外科治疗且随访至少12个月的儿童脑动静脉畸形患者,分析年出血率和畸形血管巢闭塞率及相关影响因素。平均随访136个月,伽玛刀术后年出血率为2.8%,5年和10年 actuarial 闭塞率分别为64%和81%;较高的Spetzler-Martin分级与潜伏期颅内出血显著相关,术前未行栓塞和较高的边缘剂量是预测畸形血管巢闭塞的显著因素。作者认为伽玛刀是预防儿童脑动静脉畸形未来出血的合理治疗选择,对于较高Spetzler-Martin分级的动静脉畸形,可考虑联合血管内栓塞治疗以预防破裂。

要点

  • 儿童脑动静脉畸形伽玛刀术后年出血率为2.8%,3年、5年、10年累积出血率分别为3.3%、8.5%、11.9%。
  • 重复伽玛刀治疗后5年和10年 actuarial 畸形血管巢闭塞率分别为64%和81%。
  • 较高的Spetzler-Martin分级与潜伏期颅内出血显著相关(P < 0.001)。

核心结论

  • 伽玛刀放射外科是预防儿童脑动静脉畸形未来出血的合理治疗选择。
  • 由于较高Spetzler-Martin分级的动静脉畸形在潜伏期更易出血,可考虑联合血管内栓塞治疗以预防动静脉畸形破裂。

研究设计与样本

  • 回顾性分析189例年龄≤15岁、接受伽玛刀放射外科治疗且随访至少12个月的儿童脑动静脉畸形患者。
  • Spetzler-Martin分级:I级29例(15%)、II级57例(30%)、III级82例(43%)、IV级16例(9%)、V级5例(3%)。
  • 中位治疗体积为2.2 cm³,中位边缘剂量为20 Gy。

主要发现

  • 平均随访136个月,在累计813年的畸形血管巢闭塞潜伏期内发生23次出血,伽玛刀术后年出血率为2.8%。
  • 伽玛刀术后3年、5年、10年累积出血率分别为3.3%、8.5%、11.9%。
  • 较高的Spetzler-Martin分级与潜伏期颅内出血显著相关(P < 0.001)。
  • 重复伽玛刀治疗的 actuarial 畸形血管巢闭塞率在5年和10年分别为64%和81%。
  • 术前未行栓塞(P = 0.023)和较高的边缘剂量(P = 0.029)是预测畸形血管巢闭塞的显著因素。

关键数值与推荐

  • 伽玛刀术后年出血率为2.8%。
  • 伽玛刀术后3年、5年、10年累积出血率分别为3.3%、8.5%、11.9%。
  • 重复伽玛刀治疗后5年和10年 actuarial 畸形血管巢闭塞率分别为64%和81%。
  • 较高的Spetzler-Martin分级与潜伏期颅内出血显著相关(P < 0.001)。
  • 术前未行栓塞(P = 0.023)和较高的边缘剂量(P = 0.029)是预测畸形血管巢闭塞的显著因素。

临床怎么用

  • 作者认为伽玛刀放射外科是预防儿童脑动静脉畸形未来出血的合理治疗选择。
  • 作者建议,对于较高Spetzler-Martin分级的动静脉畸形,可考虑联合血管内栓塞治疗以预防动静脉畸形破裂。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about long-term outcomes for pediatric brain arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS). This study investigated annual hemorrhage rates and nidus obliteration rates, and the factors affecting them, in pediatric AVMs treated with GKRS. METHODS: We examined 189 pediatric AVM patients (age ≤15 years) who underwent GKRS and had at least 12 months of follow-up. The Spetzler-Martin (S-M) grade was I in 29 patients (15%), II in 57 (30%), III in 82 (43%), IV in 16 (9%), and V in 5 (3%). The median treatment volume was 2.2 cm3, and the median marginal dose was 20 Gy. RESULTS: The mean follow-up period was 136 months. During a cumulative latency period to nidus obliteration of 813 years, 23 hemorrhages occurred, resulting in an annual post-GKRS hemorrhage rate of 2.8%. The cumulative hemorrhage rates after GKRS were 3.3%, 8.5%, and 11.9% at 3, 5, and 10 years, respectively. Higher S-M grade was significantly associated with intracranial hemorrhages during the latency period (P < 0.001). The actuarial nidus obliteration rates with repeated GKRS were 64% and 81% at 5 and 10 years, respectively. Absence of pre-GKRS embolization (P = 0.023) and higher marginal dose (P = 0.029) were significant factors predicting nidus obliteration. CONCLUSIONS: GKRS is a reasonable treatment option in pediatric AVMs to prevent future hemorrhages. Because higher S-M grade AVMs are more likely to hemorrhage during the latency period, a combined therapy with endovascular embolization should be considered to prevent AVM rupture.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hasegawa T, Kato T, Naito T, et al. Long-Term Outcomes for Pediatric Patients with Brain Arteriovenous Malformations Treated with Gamma Knife Radiosurgery, Part 1: Analysis of Nidus Obliteration Rates and Related Factors. World Neurosurg. 2019. PMID: 30922904. doi:10.1016/j.wneu.2019.03.176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。